Pancreatic Cancer
Showing NaN - NaN of 80
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)
Not yet recruiting
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Baltimore, MarylandSKCCC Johns Hopkins
Aug 16, 2023
Pancreatic Cancer Trial in Baltimore (VectRx Thermal Therapy)
Recruiting
- Pancreatic Cancer
- VectRx Thermal Therapy
-
Baltimore, MarylandUniversity of Maryland
Jul 26, 2023
Pancreatic Cancer Trial in Baltimore (Tislelizumab, SX-682)
Not yet recruiting
- Pancreatic Cancer
-
Baltimore, MarylandJohns Hopkins SKCCC
Jan 23, 2023
Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)
Active, not recruiting
- Pancreatic Cancer
- Cyclophosphamide
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Jan 5, 2023
Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1
Active, not recruiting
- Hepatocellular Carcinoma
- +11 more
- Part 1 TPST-1120
- +3 more
-
San Francisco, California
- +10 more
Nov 1, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)
Recruiting
- Pancreatic Cancer
- Tadalafil
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 23, 2022
NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- CPI-006
- +2 more
-
Tucson, Arizona
- +26 more
Aug 1, 2022
Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,
Recruiting
- Advanced Malignant Neoplasm
- +5 more
- AMXI-5001:Dose Escalation Phase I
- AMXI-5001:Dose Expansion Phase II
-
Phoenix, Arizona
- +7 more
Jul 18, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
High Risk Cancer, Pancreatic Cancer Trial in Baltimore (KRAS peptide vaccine)
Recruiting
- High Risk Cancer
- Pancreatic Cancer
- KRAS peptide vaccine
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Jun 1, 2022
Pancreatic Cancer Trial in Baltimore (High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT))
Recruiting
- Pancreatic Cancer
- High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT)
-
Baltimore, MarylandJohns Hopkins Hospital
Jun 3, 2022
Pancreatic Cancer Trial in Baltimore (PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.)
Recruiting
- Pancreatic Cancer
- PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022
Pancreas Cancer, Pancreatic Cancer, Cancer of the Pancreas Trial in Saint Louis (biological, drug, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- Neoantigen Peptide Vaccine
- +2 more
-
Baltimore, Maryland
- +1 more
Mar 15, 2022
Pancreatic Cancer, Periampullary Adenocarcinoma Trial in Baltimore (Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Pancreatic Cancer
- Periampullary Adenocarcinoma
- Stereotactic Body Radiation Therapy (SBRT)
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 9, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)
Active, not recruiting
- Pancreatic Cancer
- Cyclophosphamide
- +3 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022
Pancreatic Cancer Trial in Baltimore, Milwaukee (Cyclophosphamide, Nivolumab, GVAX Pancreas Vaccine)
Active, not recruiting
- Pancreatic Cancer
- Cyclophosphamide
- +3 more
-
Baltimore, Maryland
- +1 more
Mar 3, 2022
Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas Trial in Baltimore, Saint Louis (biological, device, procedure)
Active, not recruiting
- Pancreatic Cancer
- +2 more
- Personalized neoantigen DNA vaccine
- +2 more
-
Baltimore, Maryland
- +1 more
Sep 15, 2021